Related Experiment Video
Updated: Jul 30, 2025

Mesenchymal Stem Cell Isolation from Pulp Tissue and Co-Culture with Cancer Cells to Study Their Interactions
Published on: January 7, 2019
Mesenchymal stem cells- an excellent therapeutic agent for cancer
Anjilikal TomyTomcy1, Edakkadath Raghavan Sindhu2
1Department of Human Genetics and Molecular Medicine, Central University of Punjab, Bathinda, India.
Abstract:
Despite rapid advancement in research of diagnostics and therapeutics, cancer is the most dangerous disease-causing millions of deaths worldwide. Many of the conventional anticancer therapies can even lead to developing resistance to therapy and recurrence of cancer. To find a new, alternative treatment strategy for a variety of ailments scientists and researchers have turned their attention to cell therapies and regenerative medicine. Stem cells are now being researched for their extensive potential application in therapy for several incurable illnesses including cancer. One of the most often employed cell types for regenerative medicine is mesenchymal stem cells. Mesenchymal stem cells (MSCs) are considered a promising source of stem cells in personalized cell-based therapies. The inherent tumor tropic and immune-modulatory properties of MSCs can be used to target cancer cells. This review aims to focus on the anticancer properties of MSCs and their effect on different signaling pathways. Later on, we discuss the advantages of engineered MSCs over non-engineered MSCsin cancer therapy.
Insights
Mesenchymal stem cells (MSCs) show promise in cancer therapy due to their tumor-targeting and immune-modulating abilities. This review explores their anticancer properties and the benefits of engineered MSCs for improved cancer treatment strategies.
Area of Science:
- Oncology
- Regenerative Medicine
- Cell Therapy
Background:
- Cancer remains a leading cause of death worldwide, with conventional therapies often leading to resistance and recurrence.
- Cell therapies and regenerative medicine, particularly using stem cells, offer alternative treatment strategies.
- Mesenchymal stem cells (MSCs) are a key focus in regenerative medicine due to their therapeutic potential.
Purpose of the Study:
- To review the anticancer properties of mesenchymal stem cells (MSCs).
- To examine the effects of MSCs on various cancer signaling pathways.
- To discuss the advantages of engineered MSCs in cancer therapy.
Main Methods:
- Literature review focusing on mesenchymal stem cells (MSCs) and their role in cancer.
- Analysis of studies detailing MSCs' tumor-tropic and immune-modulatory functions.
- Examination of research on engineered MSCs for enhanced therapeutic efficacy.
Main Results:
- MSCs possess inherent tumor-homing and immune-regulatory capabilities beneficial for cancer treatment.
- MSCs influence multiple signaling pathways relevant to cancer progression and suppression.
- Engineered MSCs demonstrate enhanced potential compared to non-engineered counterparts in preclinical cancer models.
Conclusions:
- Mesenchymal stem cells (MSCs) represent a promising cell-based therapy for cancer.
- Targeting signaling pathways with MSCs offers a novel approach to combatting cancer.
- Further development of engineered MSCs could significantly advance cancer treatment options.
More Related Videos
Related Concept Videos
Mesenchymal Stem Cells
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Cancer Stem Cells and Tumor Maintenance
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
Stem Cell Culture
iPS Cell Differentiation

